Diana Williamson

joined CardioMed Device Consultants in April 2023. Prior to joining CardioMed, Mrs. Williamson was Vice President of Research and Development at Svelte Medical Systems, a cardiovascular device startup bringing to market a new approach to coronary stenting. Mrs. Williamson led Svelte product development from inception to commercialization. She championed complex, multi-engineering testing of Class III medical devices for US, Japan, and Europe; won approval from regulators for commercialization, IDE clinical trials, and FDA PMA approval, SLENDER IDS® and DIRECT RX®. Directed and continuously optimized complex design control process to deliver product development in compliance with quality systems, FDA 21 CFR Part 820 and ISO 13485, and Regulation (EU) 2017/745 MDR. Before that, a project Lead Engineer at Cordis, then a Johnson & Johnson Company, where her work focused on neurovascular, coronary and peripheral product development. She also served as a Lead Engineer at Concentric Medical (now Stryker) working with delivery and ischemic stroke products. Mrs. Williamson began her career as an R&D Engineer in the product development group at Guidant Corporation, division of Vascular Interventions (now Abbott Vascular).

An inventor of 7 US issued patents and several patents pending, Mrs. Williamson holds a BS in Mechanical Engineering from the Massachusetts Institute of Technology.